in pursuit of better
The founders of Vizuri Health Sciences, the precursor to Propella Therapeutics, had a shared vision to build a respected and successful pharmaceutical company that would bring real benefit to others.
As the PRL-02 oncology program began to mature, the decision was made to separate the biotechnology (Propella) and the Vizuri Consumer Health Products businesses. Thus, Propella was formed to bring focus to the advancement of the pipeline of cancer treatment candidates.
The creation of Propella focused financial investment and management expertise on the advancement of select, high value oncology products.